FDA Approved: VIOKACE — Supplemental Application (Aimmune Therapeutics, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Viokace (pancrelipase) by Aimmune Therapeutics, expanding its labeling for exocrine pancreatic insufficiency due to …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Exocrine Pancreatic Insufficiency
• Pancreatic Cancer
• Pancreatitis

Drugs mentioned

• VIOKACE (PANCRELIPASE)

Snippet

SUPPL AP for VIOKACE (PANCRELIPASE)